








































The filamentous ascomycete Podospora anserina is an 
established model system to unravel the complex 
network of pathways controlling organismal aging [1–
4]. In contrast to most other filamentous fungi, P. 
anserina wild type isolates display a limited lifespan of 
only a few weeks. During this period of time the 
morphology and physiology of growing cultures 
changes. Senescent cultures are characterized by a 
decreased growth rate, loss of fertility and an increased 
pigmentation, a phenotype that collectively is termed 
the ‘senescence syndrome’ [5].  
 
 








































Aging research on P. anserina and other model systems 
involves the identification of cellular pathways which 
contribute to an increased functional period of time 
(‘healthspan’) [3, 6]. In P. anserina several pathways 
have been identified which indeed lead to the 
phenomenon of ‘healthy aging’. These include the 
reduction of mitochondrial fission [7, 8], modulation of 
a gene encoding a SAM-dependent O-methyltransferase 
[9–11] and increase of the mitochondrial PaLON 
protease [12]. In the latter study it was shown that 
mitochondrial protein modifications (i. e., carbonylation 
and carboxymethylation) increases during aging. 
Carboxymethylation is an example for an important 
Modulation of the glyoxalase system in the aging model Podospora 
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glycation end products’ (AGEs). The mechanism 
leading to the formation of these compounds appears to 
be clear: first, a sugar aldehyde or ketone reacts with an 
amino group (e.g., a proteinaceous amino acid) in a 
non-enzymatic reaction. The resulting intermediate is a 
Schiff base which can be rearranged to fructosamine (i. 
e., Amadori product). Further modifications of the 
Amadori product can involve dehydration, cyclization 
and condensation reactions, giving eventually rise to 
AGEs [13]. AGEs are described as being highly 
detrimental because they have the potential to cause 
irreversible damage to proteins, lipids and nucleic acids 
[14–17].  
 
The highly reactive α-oxoaldehyde methylglyoxal (MG) 
is a key compound involved in the generation of AGEs. 
It is mainly generated as a by-product of glycolysis 
from the triose phosphate intermediates dihydroxy-
acetone phosphate and glyceraldehyde-3-phosphate 
[18]. To counteract the deleterious effects of MG and 
other toxic reactive carbonyl and α-oxoaldehyde 
glycating agents, organisms contain an enzymatic 
defence system comprised of glyoxalase I (lactoyl-
glutathione lyase) and glyoxalase II (hydroxyacyl-
glutathione hydrolase) [14]. α-Oxoaldehydes and 
glutathione form spontaneously a hemithioacetal that is 
converted into S-2-hydroxyacylglutathione derivatives 
by glyoxalase I. Glyoxalase II subsequently hydrolyses 
this compound to GSH and 2-hydroxycarboxylates like 
lactate. 
 
The glyoxalase system, its capacity to detoxify 
compounds involved in the generation of AGEs and an 
effect on aging have recently been the focus of several 
studies. For example, in the nematode Caenorhabditis 
elegans it was shown that activity of glyoxalase I 
declines during aging [19]. In old animals, both AGE 
and oxidative markers were found to be significantly 
increased when compared to young animals. 
Modulation of glyoxalase I activity was found to affect 
lifespan of transgenic worms (i. e., overexpression of 
CeGly1 leads to an increased mean lifespan of +29% 
whereas strains with a down-regulated CeGly1 are 
short-lived [-52 %]). In mammalian cell cultures (i.e., 
WI-38 fibroblasts) it was demonstrated that the load of 
AGE-modified proteins increases during replicative 
senescence [20]. Proteins of the cytoplasm and 
mitochondria were found to be affected, some of the 
candidates involved in fundamental cellular functions 
like energy metabolism and quality control of proteins. 
Similar to C. elegans, increased age was associated with 
decreased glyoxalase I activity. These findings suggest 
an important role of the glyoxalase detoxification 
system in the age-related increase of damaged proteins. 
Here we report data demonstrating a clear impact of the 
glyoxalase system on the aging process of P. anserina. 
Transgenic strains overexpressing the genes encoding 
the P. anserina homologs of glyoxalase I (PaGlo1) and 
/or glyoxalase II (PaGlo2) and a PaGlo1 deletion 
mutant (ΔPaGlo1) were generated, verified and 
characterized. Our data demonstrate that the glyoxalase 
system is an efficient component in the network of 
pathways affecting aging and lifespan of P. anserina. 
Enhancing the system via genetic manipulation is 





Identification of PaGlo1 and PaGlo2 in the genomic 
sequence of P. anserina 
 
The published amino acid sequences of Saccharomyces 
cerevisiae GLO1 (UniProt accession number P50107) 
and GLO2 (UniProt accession number Q05584) were 
used to search the genomic sequence of P. anserina [21] 
for the corresponding homologs via the BlastX (protein 
sequence vs. nucleotide sequence) algorithm [22]. For 
each protein, one homolog, designated PaGLO1 and 
PaGLO2, respectively, was identified. The sequence 
homology of PaGLO1 and PaGLO2 to their S. 
cerevisiae counterparts is strongly conserved, 
displaying 42% and 48% sequence identity, respectively 
(Figure 1). In the PaGLO1 sequence, a signature 
glyoxalase I motif was identified (amino acid positions 
165-186) by an in silico analysis using Expasy Prosite. 
It is located in the central region of the protein and 
contains a conserved histidine residue which is 
implicated to bind the zinc cofactor in human GLO1 
[23] (Figure 1).  
 
The available genome sequence of P. anserina is 
derived from wild type strain ‘S’. Since all experiments 
in the current study were performed with a different 
wild type strain, ‘s’, the two genes from this strain were 
sequenced and the gene sequences were compared with 
the published sequences. No differences within the 
genes between the two strains were identified. The 
accession numbers assigned by UniProt are B2AQW8 
(PaGLO1) and B2B554 (PaGLO2), respectively.  
 
Generation and verification of transgenic PaGlo1 
and PaGlo2 P. anserina strains 
 
After the identification of PaGlo1 and PaGlo2 we set 
out to characterize the glyoxalase system of P. anserina 
by creating and analyzing various transgenic glyoxalase 
strains (i. e., single PaGlo1 overexpression, single 
PaGlo2 overexpression,  double  PaGlo1/PaGlo2 
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modulation of the glyoxalase system in P. anserina 
were constructed, verified and transformed into wild 
type protoplasts. Three independent putative 
overexpression transformants for PaGlo1 and PaGlo2, 
respectively, were selected on hygromycin B-containing 
medium. Transformants in which PaGlo1 is deleted 
were selected by growth on phleomycin-supplemented 
medium.  PaGlo1/PaGlo2_OEx double mutants were 
generated by crossing the single overexpression mutants 
and selection of progeny in which recombination 
resulted in the combination of the PaGlo1 and PaGlo2 
overexpression cassettes in one nucleus. The complete 
integration of the PaGlo1 or PaGlo2 expression 
cassettes into the genome and the deletion of PaGlo1 







































shown). Subsequently, Western-blot analyses were 
performed using newly generated specific polyclonal 
peptide antibodies against PaGLO1 and PaGLO2, 
respectively (Figure 2). All PaGlo1_OEx and 
PaGlo2_OEx transformants were found to contain 
significantly elevated levels of PaGLO1 and PaGLO2, 
respectively (Figure 2 A). As expected, the PaGLO1 
protein is not detectable in the ΔPaGlo1 strain (Figure 2 
A). However, in some transformants (e.g., PaGlo2_OEx 
strains) a further signal is visible, slightly above 
PaGLO1. This additional band is possibly due to 
unspecific cross-reaction of the polyclonal PaGLO1 
antibody. The successful selection of PaGlo1/PaGlo2_ 
OEx double mutants was verified by the demonstration 
of strongly elevated levels of both PaGLO1 and 









































Figure  1.  Homology  analysis  between  P.  anserina and  yeast  proteins  of  the  glyoxalase
system. A Comparison of the amino acid sequences of glyoxalase I proteins from P. anserina (PaGLO1,




the  yeast  sequences  the  amino  acid  identity  relative  to  the  P.  anserina  proteins  is  shown.  Non‐
homologous and homologous amino acids are indicated in red and green colour, respectively.  
   












































Growth tests on media supplemented with additional 
glucose and MG 
 
Next we tested whether altered expression of genes 
encoding components of the glyoxalase system has an 
effect on growth rate under different conditions. It is 
known that elevated levels of glucose lead to the 
formation of increased MG levels [24]. Therefore we 
first investigated growth of the transformants on 
medium supplemented with elevated levels of glucose 













































rate were found when the different genetically modified 
strains were grown on synthetic medium (PASM) with 
2% glucose compared to the wild type (Table 1). It is 
important to note that these types of experiments need 
to be performed simultaneously by growing the strains 
to be compared in one set of experiment. This is crucial 
because even small changes in conditions (e.g., media 
composition) can lead to differences in reads-outs.  
 
In a second set of experiments, we challenged the 









Coomassie  were  performed  as  loading  controls.  Accession  numbers:  PaGLO1:  B2AQW8  (UniProt);
PaGLO2: B2B554 (UniProt); PaPRE3: Pa_5_4560 (Podospora anserina sequencing consortium). 
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containing 1% glucose and increasing concentrations of 
MG (i. e., 40 µM, 80 µM, 400 µM). While all strains 
were found to grow only very weakly on medium 
supplemented with 400 µM MG, the addition of low 
doses of MG (40 µM) had no effect on the growth rate 
of the wild type and the overexpression mutants 
PaGlo2_OEx and PaGlo1/PaGlo2_OEx. Under these 















































damage and affects mycelial growth. In contrast, 
PaGlo1_OEx mutants are characterized by an increased 
growth rate compared to the wild type (+ 7.7%). 
Moreover, the ΔPaGlo1 strain is unable to grow at all 
on PASM 1% glucose + 40 µM MG demonstrating an 
essential role of PaGLO1 to detoxify MG. The same 
tendency is observed when higher MG doses (80 µM) 
are applied, but on this medium PaGlo1_OEx strains do 
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glucose    
PASM 2% 
glucose    
            














100%    
WT = 
100%   
WT 0.58     0.64     
PaGlo1_OEx  0.58  0  n. s.  0.63  - 1.6  n. s. 
PaGlo2_OEx  0.63  + 7.9  n. s.  0.65  + 1.6  n. s. 
           
WT  0.55     0.64    
PaGlo1/PaGlo2_OEx  0.53  - 3.6  n. s.  0.63  - 1.6  n. s. 
           
WT  0.51     0.52    
ΔPaGlo1  0.55  + 7.8  n. s.  0.57  + 8.8  n. s. 
           
           
  PASM 1% 
glucose     PASM 1% 
glucose    
  + 40 µM  MG     + 80 µM MG    
           












   WT = 
100%     WT = 
100%   
WT 0.52     0.52     
PaGlo1_OEx  0.56  + 7.7  < 0.01  0.54  + 3.8  n. s. 
PaGlo2_OEx  0.54  + 3.8  n. s.  0.48  - 7.7  n. s. 
ΔPaGlo1  no growth  - 100.0  < 0.01  no growth  - 100.0  < 0.01 
           
WT  0.58     0.53    






























Taken together, two of the transgenic strains generated 
in this study show a different growth rate than the wild 
type under certain conditions. Demonstrating the need 
for PaGLO1 in the efficient detoxification of MG, 
ΔPaGlo1 fails to grow on MG-supplemented medium. 
The  PaGlo1_OEx mutant is characterized by an 
increased mean growth rate when cultivated on PASM 
1% glucose + 40 µM MG.  
 
Determination of median lifespan  
 
To analyze whether or not the modification in the 
abundance of enzymes of the glyoxalase system affects 
aging, we compared the lifespan of the newly generated 
transgenic strains to those of the wild type. Meiotic 
offspring resulting from crosses between transformants 
and the wild type were isolated. The identity of strains 
was verified by growth selection on hygromycin B 
(overexpression strains) or phleomycin (ΔPaGlo1 
mutant) containing medium. Subsequently, survival 
curves were recorded by measuring the lifespan of the 
isolates in race tubes with synthetic medium containing 
either 1% glucose or 2% glucose (Table 2). 
 
On PASM containing 1% glucose no significant 






























were found compared to the wild type (Table 2). In 
marked contrast, on PASM containing 2% glucose 
PaGlo1_OEx,  PaGlo1/PaGlo2_OEx and ΔPaGlo1 
strains are characterized by clear differences in lifespan 
(Figure 3, Table 2). In comparison to the wild type, 
PaGlo1_OEx and ΔPaGlo1 strains are characterized by 
a significant reduction in lifespan of 14.7% and 22.2%, 
respectively (Figure 3 A, C). In contrast, 
PaGlo1/PaGlo2_OEx shows a moderate (+ 4.3%) but 
statistically significant increased median lifespan 
(Figure 3 B). Notably, the double mutant has a ‘healthy’ 
phenotype with no impairments in mycelial growth, 
pigmentation or the formation of aerial hyphae (Figure 
4). 
Collectively, the results of this series of experiments 
demonstrate that the lifespan of specific P. anserina 
glyoxalase mutants (i. e., PaGlo1_OEx, 
PaGlo1/PaGlo2_OEx and ΔPaGlo1) is influenced on 




The central aim of this project was to study the effects 
of the glyoxalase system on P. anserina aging. Towards 
this end, we created and characterized transgenic strains 
in which the genes coding for the core components of 





  PASM 1% 
glucose     PASM 2% 
glucose    
           












   WT = 
100%     WT = 
100%   
WT 16.2  (n=21)     18.8  (n=16)     
PaGlo1_OEx  16.5 (n=62)  - 6.8  n. s.  16 (n=46)  - 14.9  < 0.01 
PaGlo2_OEx  17.3  (n=35)  - 2.3  n. s.  17.7 (n=22)  - 5.8  n. s. 
           
WT  15.2 (n=21)      15.1 (n=14)     
PaGlo1/PaGlo2_OEx  15.5 (n=21)  + 0.2  n. s.  15.8 (n=16)  + 4.6  < 0.05 
           
WT  14 (n=20)      18 (n=20)     
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overexpressed or deleted. Since it is known from 
humans that hyperglycaemia caused by diabetes [25, 
26] as well as increased glucose levels in the diet of 
nematodes [24] result in the formation of increased 
cellular MG levels we investigated the effect of the 
genetic modulation of the P. anserina glyoxalase 
systems on growth media supplemented with elevated 
levels of glucose (2% instead of 1%) and on media 














































Median lifespan of ΔPaGlo1 is strongly reduced on 
growth medium containing high levels of glucose 
(PASM with 2% glucose). Although not directly 
shown in our study, it is likely that the elevated levels 
of glucose lead to a concomitant increase of MG 
within the cell. Deletion of PaGlo1 leads to hyper-
sensitivity against MG. When added to the growth 
medium, MG efficiently kills ΔPaGlo1 strains, 















































































PaGlo1 overexpression strains are also short-lived 
compared to the wild type when grown on PASM 
containing 2% glucose. A possible reason for this 
behaviour is depletion of the reduced form of the 
tripeptide glutathione (GSH) which is directly involved 
in the detoxification of reactive oxygen species. With 
the role of GSH as one of the most important 
antioxidants within the cell and an essential cofactor of 
enzymes like glutathione peroxidase, glutathione-S-
transferase and glutaredoxin it is not surprising that 
diminished levels of this compound are associated with 
a number of diseases, e. g. Alzheimer’s disease [27] and 
Parkinson’s disease [28]. MG needs to be conjugated 
with GSH to form a so-called hemithioacetal (HTA). 
HTA is then converted to S-lactoylglutathione by 
glyoxalase I. If high amounts of PaGLO1 are present, it 
is possible that a substantial fraction of available GSH 
is converted to S-lactoylglutathione which is not able to 
fulfill the role of a cellular antioxidant. It is important to 
note that our immunodetection analyses show that 
indeed very high levels of PaGLO1 are present within 
the PaGlo1_OEx isolates. This is not surprising because 
we used a strong constitutive promoter (0.56 kBp 
fragment of a metallothionein gene promoter). In 
contrast, in the study by Morcos et al. (2008), the 
PaGLO1 homolog CeGLY1 was overexpressed under 
the control of a weaker promoter in transgenic 
nematodes. The authors reported a beneficial effect on 
lifespan by overexpression of CeGly1. Moreover, they 
overexpressed a fusion gene containing the ORF for the 
Gfp gene rather than the native gene. Consequently, the 
data of that study cannot be directly compared with our 
results. In our study, sole overexpression of PaGlo1 was 
not sufficient to improve lifespan. Only when PaGlo2 is 
also overexpressed, a beneficial effect on median 
lifespan is observed. This strengthens our hypothesis 
that GSH depletion might be the crucial problem in 
PaGlo1_OEx strains, because increased PaGLO2 levels 
facilitate release of bound GSH from S-
lactoylglutathione (PaGlo2 catalyses the hydrolysis of 
S-lactoylglutathione to form lactate and GSH). 
 
Similar findings demonstrating that forced expression of 
both genes encoding the components of the glyoxalase 
system is beneficial for survival of tobacco under salt 
stress were reported by Singla-Pareek et al. (2003) [29]. 
Moreover,  Gly1/Gly2 overexpressing tobacco mutants 
were also more resistant against exogenous MG. 
Interestingly, these mutants also produce less MG than 
their WT counterparts [30]. They contain higher levels 
of GSH and are capable to maintain higher GSH/GSSG 
ratios under stress situations. We hypothesize that a 
higher GSH/GSSG ratio in the PaGlo1/PaGlo2_OEx 
strains might represent an important contributing factor 
to an improved lifespan under high glucose conditions 
which favour increased production of MG. It is well 
known that the GSH/GSSG ratio in mitochondria is of 
key importance for cellular survival [31]. Under non-
stress conditions, mitochondrial GSH is able to cope 
with the oxidative stress generated in these organelles as 
a by-product of oxidative metabolism. However, 
depletion of GSH below a certain threshold ultimately 
leads to increased ROS-mediated damage to mtDNA, 
proteins and lipids like cardiolipin which is a 
component of the inner mitochondrial membrane. 
Oxidized cardiolipin is not able to bind one of the key 
factors of apoptosis, cytochrome-c [32]. Moreover, 
oxidized cardiolipin was demonstrated to maximize 
BAX-mediated pore formation, a further hallmark of 
apoptosis [32]. Apoptosis induction is also observed in 
the terminal stage of life in P. anserina [33]. Although 
BAX homologues are not identified in P. anserina yet, 
several other key factors involved in regulation of 
sensitivity towards apoptosis elicitation are found in this 
ascomycete (e. g., metacaspases [33], apoptosis-
inducing factors and homologues [34], the 
mitochondrial fission protein PaDNM1 [7, 8] and the 
mitochondrial peptidyl prolyl-cis,trans-isomerase 
cyclophilin D [35, 36]). Therefore, it is tempting to 
speculate that overexpression of PaGlo1 and PaGlo2 
leads to increased resistance to cellular damage and 
apoptosis induction, resulting in a prolonged lifespan 
without physiological impairments. 
 
In conclusion, here we described the glyoxalase system 
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lifespan control of this aging model. This 
experimentally well tractable model organism with a 
small, completely sequenced genome [21, 37] now 
offers excellent opportunities to further investigate the 
role of MG and the glyoxalase system as well as the 
glutathione metabolism on stress resistance and aging. 
Also, it appears to be promising to more carefully 
investigate and develop strategies to induce the 
glyoxalase system in genetically non-manipulated 
strains. Such interventions, e.g. via the application of 
mild stress conditions, may be of relevance also for 





P. anserina strains and cultivation. Overexpression 
strains PaGlo1_OEx, PaGlo2_OEx, PaGlo1/ PaGlo2_ 
OEx  and the PaGlo1 deletion strain ΔPaGlo1 are 
derived from wild type strain ‘s’ [38]. If not noted 
otherwise, the P. anserina isolates used in this study 
were grown on synthetic medium (PASM 1% glucose 
or PASM 2% glucose, respectively) in an incubation 
chamber at 27 °C. Composition of PASM (per litre): 0.5 
g KH2PO4, 0.6 g K2HPO4, 1 g urea, 2.5 µg biotin, 50 
mg thiamine, 5 mg citric acid x H2O, 5 mg ZnSO4 x 7 
H2O, 1 mg Fe(NH4)2(SO4)2 x 6 H2O, 0.25 mg CuSO4 x 
5 H2O, 0.05 mg MnSO4 x H2O, 0.05 mg H3BO3, 0.05 
mg Na2MoO4 x 2 H2O. For the determination of 
resistance against  methylglyoxal (MG), MG 
concentrations of 40 µM and 80 µM were used in 
PASM 1% glucose. MG stock solution (40% in H2O) 
was purchased from Sigma Aldrich, St Louis, MO. 
 
P. anserina  lifespan and growth rate analysis. 
Ascospores from the wild type strain ‘s’ and the 
transgenic strains were isolated and germinated on 
cornmeal agar supplemented with 60 mM ammonium 
acetate. After three days of incubation, a small piece cut 
from the juvenile mycelium was placed into a race tube 
containing 50 ml PASM 1% glucose or PASM 2% 
glucose, respectively. Growth was measured until the 
isolate stopped to grow. Such cultures were defined as 
‘dead’. The elapsed time to this point was recorded as 
the lifespan of the corresponding isolate. The median 
lifespan is defined as the time point when 50% of the 
analyzed cultures have died. Growth rates were 
determined by dividing the length of the mycelia by the 
time it took to grow. Individual differences in growth 
rate and lifespan of the WT controls observed in 
experiments conducted in independent experiments at 
different times are due to slight environmental 
variations. Therefore, in each individual experiment, 
freshly prepared wild type isolates were used as control.  
Homology analyses. Homology between related 
proteins was determined using the BLOSUM62 
algorithm implemented in ‘Clone Manager Suite 6’ 
(Scientific and Educational Software, Cary, NC). 
 
Constructs. To overexpress PaGlo1 in P. anserina wild 
type, the gene including the terminator region was 
amplified using primers XbaI-Glx1-f (5’- 
AATCTAGAATGGCGTCGACTACTGATG -3’) and 
PstI-Glx1-r (5’- AACTGCAGTGTGACCCATCAGTT 
ATCC -3’). The PCR fragment was cloned after 
digestion into the XbaI/PstI site of vector pExMthph 
[39] containing a 0.56 kbp promoter fragment of the 
metallothionein gene, PaMt1 [40]. The resulting vector 
(termed pGlx1Ex) was transformed into wild type 
protoplasts. For overexpession of PaGlo2 in the genetic 
background of the wild type, the gene including the 
terminator region was amplified using primers BamHI-
Glx2-f (5’-AAGGATCC ATGCATATCCGGTCTATT 
CC-3’) and HindIII-Glx2-r (5’-AAAAGCTT AGCGAA 
CCATAAAATCCG-3’). The PCR fragment was cloned 
after digestion into the BamHI/HindIII site of vector 
pExMthph. The resulting plasmid (termed pGlx2Ex) 
was transformed into wild type protoplasts. 
 
Deletion of PaGlo1 in wild type strain ‘s’ was 
performed according to a previously published method 
[41]. First, small flanking regions of the PaGlo1 gene 
were amplified using for the 5’ flank oligonucleotides 
KoGlx1 (5’-TTGGTACC CAACTTGTCACTATCAGC 
-3’) and KoGlx2 (5’-CCCAAGCTT AAATTCTCATT 
CATTAGC-3’), and KoGlx3 (5’-AAACTAGT 
GAAGGGCGGATATGCAGG-3’) and KoGlx4 (5’- 
AAGCGGCCGCTACACATGGAAGGAGTGG-3’) for 
amplification of the 3’ flank. The 5’ fragment was 
digested with KpnI and HindIII and ligated into plasmid 
pKO3. The resulting plasmid was named pGlx1Ko1. 
The 3’ fragment was digested with BcuI and NotI and 
ligated into pGlx1Ko1. The resulting plasmid was 
termed pGlx1Ko2 and contains both fragments flanking 
a resistance cassette bearing phleomycin and blasticidin 
marker genes for fungal and bacterial selection, 
respectively. The resistance cassette with the flanking 
regions was excised by restriction with NotI and KpnI 
and used to transform E. coli strain KS272 bearing the 
plasmid pKOBEG [42], which contains the ‘red’ region 
of bacteriophage lambda, and the cosmid 3A7 [43] 
bearing the PaGlo1 locus. Homologous recombination 
between the flanks of the resistance cassette and cosmid 
3A7 lead to generation of cosmid ∆Glx1#3A7, which 
contains the phleomycin-blasticidin cassette with large 
flanking genomic regions. The cosmid was isolated and 
used to transform P. anserina wild type strain ‘s’. 
Positive transformants (i.e., PaGlo1 deletion strains) 
were selected by growth on phleomycin containing 
   
www.impactaging.com                   977                                   AGING,   December 2010, Vol.2 No.12medium. The cosmid also bears a hygromycin B 
resistance cassette, which is integrated upon its ectopic 
integration into the genome. Therefore, positive 
transformants must not be able to grow on medium 
supplemented with hygromycin B. 
 
DNA sequencing. DNA sequencing was performed by 
‘Scientific Research and Development GmbH’, 
Oberursel, Germany. 
 
P. anserina transformation. The constructs used in this 
study were transformed into P. anserina protoplasts 
according to previously published protocols [44, 45]. 
5*10
7 protoplasts were used in each transformation. 
 
Total protein extraction from P. anserina. Total proteins 
were isolated by grinding approximately 3–4 g of wet 
mycelium in liquid nitrogen. The mycelial powder was 
dissolved in 1 mL extraction buffer (5 mM EDTA, 50 
mM Na2HPO4, 1/100 Protease Inhibitor Cocktail 
[Calbiochem, Nottingham, UK], pH 7.5) and disrupted 
by vortexing cycles. The sample was centrifuged 
(25700 g, 10 min, Sorvall GSA SLA-7500 rotor) and 
the concentration of the supernatant was determined 
according to a modified protocol as described by 
Bradford using Roti-Nanoquant (Roth, Karlsruhe, 
Germany).  
 
Generation of antibodies. Antibodies directed against 
components of the P. anserina glyoxalase system were 
newly generated: α-PaGLO1 raised against a PaGLO1 
specific synthetic peptide ([Ac]-CVQNERFADKANF-
[OH]; New England Peptide, Gardner, MA) 
corresponding to amino acids 302-313 and α-PaGLO2 
raised against a PaGLO2 specific synthetic peptide 
([Ac]-CFTIGDEKQHNV-[amide]; New England 
Peptide, Gardner, MA) corresponding to amino acids 
213-223. 
 
SDS-PAGE and Western blot analysis. 100  μg of 
mitochondrial protein was incubated at 95 °C for 10 
min in loading buffer (0.1 M Tris [pH 6.8], 6% SDS, 
6% glycerol, 0.6 M ß-mercaptoethanol, 0.08% 
bromophenolblue) and was subsequently separated by 
using either 10 or 15% SDS-PAGE, respectively. After 
electrophoretic separation, proteins were transferred to a 
PVDF membrane (Immobilon-FL, Millipore, 
Schwalbach, Germany) using an electro-blotting system 
(Bio-Rad, Munich, Germany). Transfer membranes 
were incubated in blocking buffer (Li-Cor, Lincoln, NE, 
USA) for 1 h at RT and subsequently probed with the 
polyclonal P. anserina PaGLO1 antibodies (α-PaGLO1) 
(1:2000, overnight, 4 °C) or the polyclonal P. anserina 
PaGLO2 antibodies (α-PaGLO2) (1:2000, overnight, 4 
°C). Labelling was detected with secondary antibodies 
(IRDye conjugated goat-α-rabbit [Li-Cor, Lincoln, NE, 
USA], 1:15000, 1 h, RT) and scanning the blots with an 
Odyssey infrared scanner (Li-Cor, Lincoln, NE, USA). 
As a loading control, transfer membranes were either 
treated with polyclonal P. anserina PaPRE3 antibodies 
directed against the β1-subunit of the 20S proteasome 
(1:2500, overnight, 4 °C) or stained with Coomassie 
Blue. 
 
Statistical analysis. Statistical analysis of the results 





This work is supported by grants of the European 
Commission (Integrated Project: PROTEOMAGE, 
Contract No. FP6-518230) and the BMBF 
(‘GerontoMitoSys’) to HDO and the NGFNplus-
Neuron-Parkinson network to SG. Support by the 
Cluster of Excellence Macromolecular Complexes, 
Frankfurt, is gratefully acknowledged. 
 
CONFLICT OF INTERESTS STATEMENT 
 
The authors of this manuscript have no conflict of 






2.  Lorin  S,  Dufour  E,  Sainsard‐Chanet  A.  Mitochondrial 
metabolism  and  aging  in  the  filamentous  fungus  Podospora 
anserina. Biochim Biophys Acta 2006; 1757: 604‐610. 
3.  Osiewacz  HD,  Brust  D,  Hamann  A,  Kunstmann  B,  Luce  K, 
Müller‐Ohldach  M,  Scheckhuber  CQ,  Servos  J,  Strobel  I. 
Mitochondrial  pathways  governing  stress  resistance,  life,  and 
death in the fungal aging model Podospora anserina. Ann N Y 
Acad Sci 2010; 1197: 54‐66. 
4.  Osiewacz  HD,  Kimpel  E.  Mitochondrial‐nuclear  interactions 
and lifespan control in fungi. Exp Gerontol 1999; 34: 901‐909. 
5.  Rizet  G.  Sur  l'impossibilité  d'obtenir  la  multiplication 
végétative  ininterrompue  illimitée  de  l'ascomycète  Podospora 
anserina. C R Acad Sci Paris 1953; 237: 838‐855. 













www.impactaging.com                    978                                 AGING, December 2010, Vol.2 No.129.  Kunstmann  B,  Osiewacz  HD.  Over‐expression  of  an  S‐
adenosylmethionine‐dependent  methyltransferase  leads  to  an 
extended lifespan of Podospora anserina without impairments in 
vital functions. Aging Cell 2008; 7: 651‐662. 
10.  Kunstmann  B,  Osiewacz  HD.  The  S‐adenosylmethionine 
dependent O‐methyltransferase PaMTH1: a longevity assurance 
factor  protecting  Podospora  anserina  against  oxidative  stress. 
AGING 2009; 1: 1‐7. 
11.  Knab  B,  Osiewacz  HD.  Methylation  of  polyphenols  with 
vicinal  hydroxyl  groups:  A  protection  pathway  increasing 
organismal lifespan. Cell Cycle 2010; 9: 3387‐3388. 
12. Luce K, Osiewacz HD. Increasing organismal healthspan by 






methylglyoxal  in  physiological  systems‐‐role  in  ageing  and 
disease. Drug Metabol Drug Interact 2008; 23: 125‐150. 
15. Rabbani N, Thornalley PJ. Dicarbonyls linked to damage in 
the  powerhouse:  glycation  of  mitochondrial  proteins  and 
oxidative stress. Biochem Soc Trans 2008; 36: 1045‐1050. 




18.  Shinohara  M,  Thornalley  PJ,  Giardino  I,  Beisswenger  P, 
Thorpe  SR,  Onorato  J,  Brownlee  M.  Overexpression  of 
glyoxalase‐I  in  bovine  endothelial  cells  inhibits  intracellular 
advanced  glycation  endproduct  formation  and  prevents 
hyperglycemia‐induced  increases  in  macromolecular 
endocytosis. J Clin Invest 1998; 101: 1142‐1147. 
19. Morcos M, Du X, Pfisterer F, Hutter H, Sayed AA, Thornalley 
P,  Ahmed  N,  Baynes  J,  Thorpe  S,  Kukudov  G,  Schlotterer  A, 
Bozorgmehr  F,  El  Baki  RA  et  al.  Glyoxalase‐1  prevents 


























26.  Wang  H,  Meng  QH,  Gordon  JR,  Khandwala  H,  Wu  L. 
Proinflammatory and proapoptotic effects of methylglyoxal on 











tobacco  plants  overexpressing  glyoxalase  enzymes  resist  an 
increase  in  methylglyoxal  and  maintain  higher  reduced 
glutathione  levels  under  salinity  stress.  FEBS  Lett  2005;  579: 
6265‐6271. 
31. Mari M, Morales A, Colell A, Garcia‐Ruiz C, Fernandez‐Checa 
JC.  Mitochondrial  glutathione,  a  key  survival  antioxidant. 
Antioxid Redox Signal 2009; 11: 2685‐2700. 
32. Mari M, Colell A, Morales A, Caballero F, Moles A, Fernandez 
A,  Terrones  O,  Basanez  G,  Antonsson  B,  Garcia‐Ruiz  C, 
Fernandez‐Checa JC. Mechanism of mitochondrial glutathione‐
dependent  hepatocellular  susceptibility  to  TNF  despite  NF‐
kappaB activation. Gastroenterology 2008; 134: 1507‐1520. 




PaAmid2,  two  genes  encoding  mitochondrial  AIF‐like 
oxidoreductases  of  Podospora  anserina,  leads  to  increased 
stress  tolerance  and  lifespan  extension.  Curr  Genet  2010;  56: 
225‐235. 
35.  Brust  D,  Daum  B,  Breunig  C,  Hamann  A,  Kühlbrandt  W, 
Osiewacz HD. Cyclophilin D links programmed cell death and or‐
ganismal aging in Podospora anserina. Aging Cell 2010; 9: 761‐775. 
36.  Groebe  K,  Krause  F,  Kunstmann  B,  Unterluggauer  H, 
Reifschneider  NH,  Scheckhuber  CQ,  Sastri  C,  Stegmann  W, 
Wozny W, Schwall GP, Poznanovic S, Dencher NA, Jansen‐Dürr P 
et  al.  Differential  proteomic  profiling  of  mitochondria  from 
Podospora anserina, rat and human reveals distinct patterns of 
age‐related oxidative changes. Exp Gerontol 2007; 42: 887‐898. 
37.  Osiewacz  HD,  Clairmont  A,  Huth  M.  Electrophoretic 




39.  Zintel  S,  Schwitalla  D,  Luce  K,  Hamann  A,  Osiewacz  HD. 
Increasing mitochondrial superoxide dismutase abundance leads 








www.impactaging.com                   979                                  AGING, December 2010, Vol.2 No.1241. Hamann A, Krause K, Werner A, Osiewacz HD. A two‐step 









of  the  ascomycete  Podospora  anserina:  identification  of  the 
mating‐type  locus  on  chromosome  VII  of  electrophoretically 
separated  chromosomes.  Appl  Microbiol  Biotechnol  1991;  35: 
38‐45. 
45.  Stumpferl  SW,  Stephan  O,  Osiewacz  HD.  Impact  of  a 
disruption of a pathway delivering copper to mitochondria on 




www.impactaging.com                   980                                  AGING, December 2010, Vol.2 No.12